Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206472) titled 'A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia' on Sept. 25.
Study Type: Observational
Primary Sponsor: Daiichi Sankyo
Condition:
Primary Hypercholesterolaemia
Mixed Dyslipidemia
Intervention:
Drug: Combination of bempedoic acid and ezetimibe
Recruitment Status: Not recruiting
Date of First Enrollment: November 30, 2025
Target Sample Size: 2560
To know more, visit https://clinicaltrials.gov/study/NCT07206472
Published by HT Digital Content Services with permission from Health Daily Digest....